These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10409861)

  • 21. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease.
    Fireman E; Haimsky E; Noiderfer M; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):144-8. PubMed ID: 12870725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of beryllium sensitization and disease in nuclear workers.
    Kreiss K; Mroz MM; Zhen B; Martyny JW; Newman LS
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):985-91. PubMed ID: 8214955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.
    Williams WJ; Williams WR
    Thorax; 1983 Jan; 38(1):41-4. PubMed ID: 6845261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening blood test identifies subclinical beryllium disease.
    Kreiss K; Newman LS; Mroz MM; Campbell PA
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berylliosis as an auto-immune disorder.
    Reeves AL
    Ann Clin Lab Sci; 1976; 6(3):256-62. PubMed ID: 942183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
    Price CD; Williams WJ; Pugh A; Joynson DH
    J Clin Pathol; 1977 Jan; 30(1):24-28. PubMed ID: 320228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of the functional state of the lymphocytes in berylliosis studied by the blast transformation method].
    Shpakova AP; Ermakova NG
    Sov Med; 1979 Apr; (4):20-4. PubMed ID: 312533
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic berylliosis of the lung: report of a case.
    Chandrashekar HB; Ramesh BR; Chitra D
    Indian J Chest Dis Allied Sci; 1996; 38(1):45-8. PubMed ID: 16892748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sarcoidosis and berylliosis].
    Soriano D; Quartucci C; Agarwal P; Müller-Quernheim J; Frye BC
    Internist (Berl); 2022 May; 63(5):557-565. PubMed ID: 35397695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients.
    Müller-Quernheim J; Gaede KI; Fireman E; Zissel G
    Eur Respir J; 2006 Jun; 27(6):1190-5. PubMed ID: 16540500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of in vivo and in vitro measures of beryllium sensitization.
    Bobka CA; Stewart LA; Engelken GJ; Golitz LE; Newman LS
    J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
    Stephan CH; Sauvé S; Fournier M; Brousseau P
    J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hygienic and toxicological aspects of occupational and environmental exposure to beryllium.
    Bencko V; Vasil'eva EV
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):403-17. PubMed ID: 6663073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
    Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
    Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.